While classical low-flow, low-gradient AS patients show poorer survival than high-gradient AS at first glance, adjusting for baseline risk reveals a different story: patient risk profile, not flow status, is key. Careful pre-TAVI planning can enhance outcomes and avoid futile interventions. #TAVI #EAPCI #PCRLV #aorticstenosis ow.ly/zMKx50Uc6g7 @cardaioli @G_Tarantini01 @ChiaraFraccaro

In patients undergoing valve-in-valve (ViV) interventions for failed surgical bioprosthetic valves, performing bioprosthetic valve fracture (BVF) after transcatheter heart valve (THV) implantation, compared to BVF performed before THV implantation or no BVF, resulted in better immediate hemodynamic performance and sustained valve function without long-term trade-offs in THV performance or structural valve damage, as demonstrated in bench studies simulating up to 5 years of valve wear.#EIJBestOf @David_Meier_ @sellers_steph 👉ow.ly/hlwg50Sy4gM

This week we successfully treated the first 2 patients with the #TTVI system #EVOQUE at #StGeorgHeart! 🫀 💪🏼 Our utmost gratitude goes to our great #Team inside and outside the OR, to @EdwardsLifesci for the top-level support and our patients who placed their trust in us 🙏

This study shows that the SAPIEN 3 Ultra RESILIA (S3UR) valve offers significantly better performance for TAVR in severe aortic stenosis compared to the SAPIEN 3 (S3) valve. The S3UR valve reduces paravalvular leakage (PVL) and patient-prosthesis mismatch (PPM), especially in smaller valve sizes, without increasing procedural complications. ow.ly/QPh450S698E

Liebe Kolleginnen und Kollegen, Wir möchten Sie hiermit herzlich am 28./29. Juni 2024 zu unserem Echokardiographie-Grundkurs 🦇 am Asklepios Klinikum St. Georg, Hamburg einladen. 🫀 Zur Anmeldung geht’s hier: aerzteakademie-hamburg.de/?S… #echofirst #StGeorgHeart @asklepiosgruppe

Dear Colleagues & fellow #StructuralHeart Enthusiasts, we would like to invite you to our event Structural Heart Spotlight: TAVI 🫀this Wednesday April 17th at #StGeorgHeart 🏥 in Hamburg to join us for interactive discussions and hands-on experience on simulators! 🦾 #HeartTeam

Which matters more, aortic valve area or a high-pressure gradient? See the results of this new #JACC manuscript looking at discordant high-gradient aortic stenosis: bit.ly/3TolqHJ #vhdAS #LVEF #cvEcho @ClavelLabo @XGalloo

The DragonFly-M system is a new type of M-TEER device alternative to Mitraclip and Pascal. It has the ability to adjust leaflet tension by means of a central filler, which can be compressed to further block the regurgitant orifice, potentially allowing treatment of larger regurgitation with fewer devices. Here are the one-year results of the DRAGONFLY-DMR trial. eurointervention.pcronline.c…

Women benefit even more than men from physical activity! @BerrischR @thiele_holger @Ch_Stumpf @YoungDgk @PG13_DGK @AG14_DGK @ChristianRost10 @Steph_Achenbach sciencedirect.com/science/ar…

Complex simplification of structural heart with Echo fusion and AI. Within a few years will be Holo lens and 4D with depth perception. Here's a recent example from my lab where the workflow is routine, this is part of what we see on screen during the procedure. #UABStructural

Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement. Read more in #EHJ: academic.oup.com/eurheartj/a… #CAD #AS #TAVR #PCI #cardiotwitter @escardio @ESC_Journals

🎓Die #DGK freut sich mit der Klinik für Kardiologie & Internist. Intensivmedizin am #Asklepios Klinikum St. Georg Hamburg der @asklepiosgruppe über die erneute Auszeichnung als Fortbildungsstandort Junge Kardiologie der @YoungDgk. #Kardiologie #Herzgesundheit #StGeorgHeart

Very interesting work from the team at @HartcentrumH in the rapidly evolving field of #Sportscardiology! 1 in 6 elite endurance athletes showing reduction in #LVEF or #RVEF. But is this part of the athletic phenotype spectrum or a marker of cardiac disease? Read all about it👇🤓

…… @felixmeincke @CardioSchmidt @AGIKinterv @GhanemAlexander @tbubben @KardiologieHH

The interventional structural cardiology team (Prs. Lancellotti, Lempereur, Dulgheru, Dr. Bruls) is very pleased to share with you the results of its first percutaneous implantation of the TOPAZ biological prosthesis in the tricuspid position (TRICURE program).

The TAVI-MultiCLOSE study demonstrated the safety and efficacy of a new and easy-to-implement algorithm for percutaneous closure of large-bore arterial access after TF-TAVI. Read more. #EAPCI ow.ly/qFoO50QcuNi

🫁 Positive news in #JACCINT from #TVT registry! Study on #TAVR in minimally symptomatic #AS shows higher 1-yr survival & improved health status compared to more symptomatic pts! Even small improvements matter. bit.ly/47oNboU #vhdAS #CardioTwitter

In redo-TAVI, full redo-THV expansion is achieved only with SAPIEN 3 in SAPIEN 3, utilizing pre- and post-dilatation. This emphasizes the pivotal role of CT assessment and underscores the necessity of pre- and post-dilatation considerations. #EAPCI ow.ly/ViTC50QaXum

Good saturday night case - young pt, aortic valve endocarditis refractory cardiogenic shock. Transcaval ICE-guided LAVA-ECMO without pre- contrast CT. Full cardiocirculatory support with LV venting w only peripheral venous access. Thanks to @PedroMDMSc @HFHCardioFellow

This study showed that the staging system provided prognostic value across all AS subtypes. However, higher mortality was observed in classical LF LG-AS patients compared to other AS subtypes, even in the early stages. ow.ly/uW5950Q5uLk